HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Allopurinol induces renal toxicity by impairing pyrimidine metabolism in mice.

Abstract
We investigated the relationship between the toxic effect of allopurinol and pyrimidine metabolism in mice. Allopurinol-induced increases in plasma transaminase levels in dinitrofluorobenzene (DNFB)-sensitized mice were not affected by uridine. In contrast, plasma creatinine and BUN tended to decrease 18 hr after the last injection of uridine. Both plasma and urinary orotidine (OD) were detected in DNFB-sensitized mice after administration of a single dose of allopurinol. In contrast, TEI-6720, a newly synthesized xanthine oxidase/xanthine dehydrogenase inhibitor, caused neither pyrimidine metabolism abnormality nor renal impairment in DNFB-sensitized mice. Also, normal mice administered high doses of allopurinol showed abnormal pyrimidine metabolism together with renal toxicity which could be ameliorated by uridine, indicating that allopurinol essentially causes pyrimidine metabolism abnormality leading to renal impairment. In DNFB-sensitized mice, allopurinol increased urinary OD excretion to an extent similar to that in normal mice administered the same dose of allopurinol. However, renal impairment by allopurinol was more striking in DNFB-sensitized mice than in normal mice. Histopathological observations showed that allopurinol induced calculus formation in the collecting tubules and papillary duct. Calculus formation was increased by DNFB and decreased by uridine. These observations indicate that the enhancement of the renal toxicity of allopurinol by DNFB-sensitization may be due to some biological interactions between DNFB and allopurinol. In humans, it is possible that there are some biological interactions which serve to enhance the toxicity of allopurinol, resulting in the development of allopurinol hypersensitivity syndrome (AHS). In contrast, TEI-6720, had no effect on pyrimidine metabolism and showed no toxic effect.
AuthorsH Horiuchi, M Ota, S Nishimura, H Kaneko, Y Kasahara, T Ohta, K Komoriya
JournalLife sciences (Life Sci) Vol. 66 Issue 21 Pg. 2051-70 (Apr 14 2000) ISSN: 0024-3205 [Print] ENGLAND
PMID10823345 (Publication Type: Journal Article)
Chemical References
  • Antimetabolites
  • Pyrimidines
  • Allopurinol
  • Dinitrofluorobenzene
  • Uridine
Topics
  • Allopurinol (toxicity)
  • Animals
  • Antimetabolites (toxicity)
  • Dinitrofluorobenzene (pharmacology)
  • Drug Hypersensitivity
  • Drug Interactions
  • Kidney (drug effects, metabolism)
  • Kidney Diseases (chemically induced, metabolism)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Pyrimidines (metabolism)
  • Uridine (pharmacology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password: